AmBisome® as antifungal primary prophylaxis in patients undergoing allogeneic stem cell transplantation from alternative donor: preliminary results of phase II "Prophessor" trial

被引：0
|
作者：
Ciceri, F. [1 ]
Bacigalupo, A. [2 ]
Bregni, M. [1 ]
Busca, A. [3 ]
Giardini, C. [4 ]
Scime, R. [5 ]
Visani, G. [4 ]
Balzano, R. L. [6 ]
Picaro, L. A. [6 ]
Aversa, F. [7 ]
机构：
[1] Ist Sci San Raffaele, I-20132 Milan, Italy
[2] San Martino Hosp, Genoa, Italy
[3] Le Molinette Hosp, Turin, Italy
[4] San Salvatore Hosp, Pesaro, Italy
[5] Cervello Hosp, Palermo, Italy
[6] Gilead Sci Srl, Milan, Italy
[7] Univ Perugia, I-06100 Perugia, Italy
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [1] Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial
    de Latour, Regis Peffault
    Chevret, Sylvie
    Ruggeri, Annalisa
    Suarez, Felipe
    Souchet, Laetitia
    Michonneau, David
    de Fontbrune, Flore Sicre
    Coman, Tereza
    t Rubio, Marie
    Nguyen, Stephanie
    Mohty, Mohamad
    Socie, Gerard
    BLOOD, 2016, 128 (22)
  • [2] A pilot study of AmBisome® prophylaxis in patients undergoing allogeneic related and unrelated stem cell transplantation (AlloSCT).
    Cairo, MS
    Syzmanski, J
    Harrison, LA
    Wolownik, K
    Bessmertney, O
    Del Toro, G
    Bradley, MB
    Yamashiro, DJ
    Garvin, JH
    BLOOD, 2001, 98 (11) : 354B - 354B
  • [3] VORICONAZOLE AS PRIMARY ANTIFUNGAL PROPHYLAXIS IN RECIPIENTS OF ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION FROM ALTERNATIVE DONORS
    Cozzi, J.
    Basso, A.
    Lein, J.
    Saslavsky, J.
    Saslavsky, M.
    Pilli, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S283 - S284
  • [4] VORICONAZOLE AS ANTIFUNGAL PROPHYLAXIS DURING NEUTROPENIC PHASE IN CHILDREN UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
    Molina, J. R.
    Buenasmananas, D.
    Garcia-Torres, E.
    Rodriguez-Villa, A.
    Rojas, R.
    Martin, C.
    Serrano, J.
    Gomez, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S375 - S376
  • [5] Antifungal prophylaxis with itraconazole oral solution in patients undergoing allogeneic hematopoietic stem cell transplantation
    Skoetz, N
    Fuchs, M
    Holtick, U
    Scheid, C
    Diehl, V
    Waldschmidt, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S192 - S192
  • [6] Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Michaela Döring
    Ulrike Hartmann
    Annika Erbacher
    Peter Lang
    Rupert Handgretinger
    Ingo Müller
    BMC Infectious Diseases, 12
  • [7] Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Doering, Michaela
    Hartmann, Ulrike
    Erbacher, Annika
    Lang, Peter
    Handgretinger, Rupert
    Mueller, Ingo
    BMC INFECTIOUS DISEASES, 2012, 12
  • [8] Voriconazole as antifungal prophylaxis in 124 high-risk patients undergoing allogeneic stem cell transplantation
    Clerici, D.
    Malato, S.
    Giglio, F.
    Greco, R.
    Mastaglio, S.
    Matteazzi, F.
    Assanelli, A.
    Marcatti, M.
    Bernardi, M.
    Peccatori, J.
    Fumagalli, L.
    Corti, C.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S227 - S227
  • [9] Antifungal prophylaxis in allogeneic stem cell transplantation: Results of a retrospective cohort study
    Wolschke, Christine
    Lellek, Heinrich
    Heinzelmann, Marion
    Kroeger, Nicolaus
    Zander, Axel
    BLOOD, 2007, 110 (11) : 329B - 330B
  • [10] High-dose weekly AmBisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: A pharmacokinetic study
    Mehta, P
    Vinks, A
    Filipovich, A
    Vaughn, G
    Fearing, D
    Sper, C
    Davies, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 235 - 240
12345